Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 3/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9537582 | 0.87 | TP53 (0.53) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9537085 | 0.86 | SLC6A9 (0.58) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9537249 | 0.86 | SCN9A (0.53) | TP53 | |
| SCHEMBL9535785 | 0.86 | SLC6A9 (0.58) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9535367 | 0.85 | SLC6A9 (0.58) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9540167 | 0.85 | SLC6A9 (0.56) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9540313 | 0.84 | SLC6A9 (0.53) | SLC6A9TP53MAPTLMNAENPP2 | |
| Fumaric Acid SCHEMBL10550969 | 0.83 | TP53 (0.50) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9535114 | 0.83 | SLC6A9 (0.53) | SLC6A9TP53MAPTLMNAENPP2 | |
| SCHEMBL9537811 | 0.83 | SLC6A9 (0.60) | SLC6A9TP53MAPTLMNAENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0151826-B1 | 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-03-31 | — | — | EP | disclosed |
| US-4839374-A | TREATING ALLERGIES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1989-06-13 | — | — | US | disclosed |
| US-4695575-A | ANTIHISTAMINES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1987-09-22 | — | — | US | disclosed |
| EP-0151826-A1 | 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines | JANSSEN PHARMACEUTICA N.V. (BE) | 1985-08-21 | — | — | EP | disclosed |